Literature DB >> 3830274

A C9 related channel forming protein in the cytoplasmic granules of human large granular lymphocytes.

L S Zalman, M A Brothers, H J Müller-Eberhard.   

Abstract

Large granular lymphocytes (LGL) from human blood maintained in culture for 2 to 6 weeks with IL-2 were found positive in the K562 cell killing assay. The cytoplasmic granules of the LGL were isolated, lysed and the soluble proteins were passed over a Sepharose-anti-C9 column. The retained protein was eluted with NaCl and found to consist by SDS polyacrylamide gel electrophoresis of essentially one component with a molecular weight of approximately 70 000. The protein did not give a positive precipitation test with anti-human C9 by Ouchterlony analysis, but it reacted reproducibly with anti-human C9 by Western blot analysis. By ELISA the cross reaction with human C9 was less than 1%. The C9 related lymphocyte protein lacked C9 hemolytic activity, but it formed functional pores in liposomes in presence of Ca++. These results suggest that the cytoplasmic granules of human LGL that are capable of killing NK target cells contain C9 related protein which is involved in the cellular cytotoxicity reaction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3830274     DOI: 10.1007/bf01119631

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  12 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.

Authors:  L S Zalman; M A Brothers; F J Chiu; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Identification and sequencing of cDNA clones encoding the granule-associated serine proteases granzymes D, E, and F of cytolytic T lymphocytes.

Authors:  D Jenne; C Rey; J A Haefliger; B Y Qiao; P Groscurth; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cells.

Authors:  L S Zalman; D E Martin; G Jung; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.

Authors:  D E Martin; F J Chiu; I Gigli; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.

Authors:  D E Martin; L S Zalman; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

7.  P2X receptor stimulation amplifies complement-induced haemolysis.

Authors:  J L Hejl; M Skals; J Leipziger; H A Praetorius
Journal:  Pflugers Arch       Date:  2012-11-14       Impact factor: 3.657

8.  Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.

Authors:  L S Zalman; M A Brothers; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.

Authors:  D E Martin; L S Zalman; G Jung; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes.

Authors:  L S Zalman; L M Wood; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.